Pfizer, Merck, AstraZeneca lead Big Pharma growth in Q1
Thinking differently: how AstraZeneca finds value in the competitive oncology sector through industry-leading dealmaking
GEN's List of Top Pharma and Biotech Firms
GlobalData's Top 20 global pharmaceutical companies by market cap (year ended December 31, 2018) - GlobalData
Top 25 Global Pharmaceutical Companies by Market Cap 2018 - Pharmaceutical Processing World
AstraZeneca revenue by therapeutic area 2020-2022 | Statista
Top 20 biopharmaceutical companies hold their spot despite market cap drop in Q1 2022 - Pharmaceutical Technology
Merck, Vertex and Lilly led biopharma share price gains in 2022
Prospering in the pandemic: the top 100 companies
UK Drugmaker GSK Needs to Show It's Kicked the Dealmaking Addiction - Bloomberg
AstraZeneca revenue by region 2013-2022 | Statista
Drug wars: how AstraZeneca overtook GSK in UK pharma
Top 20 global biopharmaceutical companies by market capitalization (quarter ended March 31, 2022), presented by GlobalData - GlobalData
Apple's Colossal Market Cap in Context
Market cap rebound by top 20 biopharmaceutical companies in Q2 2023 - Pharmaceutical Technology
U.S. secures 300 million doses of potential AstraZeneca COVID-19 vaccine | Reuters
Top 20 Pharmaceutical Companies by Revenue 2021 | FiercePharma
AstraZeneca (AZN) Looks to More Than Double New Cancer Drugs by 2030 - Bloomberg
Drug wars: how AstraZeneca overtook GSK in UK pharma
Half of top 20 biopharma company market cap impacted amid the IRA in Q3 2023 - Pharmaceutical Technology
AstraZeneca PLC
AstraZeneca is still a blue chip to depend on - Investors' Chronicle
GlobalData names top 25 global pharma companies by market cap
AstraZeneca stock value falls by nearly £14bn after cancer drug trial results | AstraZeneca | The Guardian
AstraZeneca revenue 2006-2022 | Statista
